Paul R. Kunk

Hematology

1215 Lee St
Charlottesville, VA 22908

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 19, 2026

Early Detection of Krukenberg Tumors Utilizing ctDNA Testing and CEA Monitoring.

Early Detection of Krukenberg Tumors Utilizing ctDNA Testing and CEA Monitoring.

Journal: Case reports in oncological medicine

Published: December 12, 2024

Outcomes associated with total neoadjuvant therapy with non-operative intent for rectal adenocarcinoma.

Outcomes associated with total neoadjuvant therapy with non-operative intent for rectal adenocarcinoma.

Journal: Frontiers in oncology

Published: January 22, 2024

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.

Journal: BMC cancer

Published: April 17, 2023

Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework.

Mobile sensing to advance tumor modeling in cancer patients: A conceptual framework.

Journal: Internet interventions

Published: February 15, 2023

ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.

ARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 17, 2021

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers.

Journal: The Journal of clinical investigation

Published: June 25, 2021

Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor Location.

Myeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor Location.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)

Published: February 12, 2021

Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer Patients.

Using Graph Representation Learning to Predict Salivary Cortisol Levels in Pancreatic Cancer Patients.

Journal: Journal of healthcare informatics research

Published: November 21, 2020

Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies.

Mismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive Morphologies.

Journal: American journal of clinical pathology

Published: December 18, 2019

Risk of Major Bleeding with Ibrutinib.

Risk of Major Bleeding with Ibrutinib.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 29, 2018

Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Journal: Cancer immunology, immunotherapy : CII

Published: May 03, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026